221 related articles for article (PubMed ID: 12814960)
1. In vitro metabolism of the mammalian soluble epoxide hydrolase inhibitor, 1-cyclohexyl-3-dodecyl-urea.
Watanabe T; Morisseau C; Newman JW; Hammock BD
Drug Metab Dispos; 2003 Jul; 31(7):846-53. PubMed ID: 12814960
[TBL] [Abstract][Full Text] [Related]
2. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
[TBL] [Abstract][Full Text] [Related]
3. Rapid determination of soluble epoxide hydrolase inhibitors in rat hepatic microsomes by high-performance liquid chromatography with electrospray tandem mass spectrometry.
Watanabe T; Hammock BD
Anal Biochem; 2001 Dec; 299(2):227-34. PubMed ID: 11730347
[TBL] [Abstract][Full Text] [Related]
4. Epoxide hydrolases in the rat epididymis: possible roles in xenobiotic and endogenous fatty acid metabolism.
DuTeaux SB; Newman JW; Morisseau C; Fairbairn EA; Jelks K; Hammock BD; Miller MG
Toxicol Sci; 2004 Apr; 78(2):187-95. PubMed ID: 14737000
[TBL] [Abstract][Full Text] [Related]
5. Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.
Zhao X; Yamamoto T; Newman JW; Kim IH; Watanabe T; Hammock BD; Stewart J; Pollock JS; Pollock DM; Imig JD
J Am Soc Nephrol; 2004 May; 15(5):1244-53. PubMed ID: 15100364
[TBL] [Abstract][Full Text] [Related]
6. Protein-reactive metabolites of carbamazepine in mouse liver microsomes.
Lillibridge JH; Amore BM; Slattery JT; Kalhorn TF; Nelson SD; Finnell RH; Bennett GD
Drug Metab Dispos; 1996 May; 24(5):509-14. PubMed ID: 8723729
[TBL] [Abstract][Full Text] [Related]
7. Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase.
Eldrup AB; Soleymanzadeh F; Farrow NA; Kukulka A; De Lombaert S
Bioorg Med Chem Lett; 2010 Jan; 20(2):571-5. PubMed ID: 19969453
[TBL] [Abstract][Full Text] [Related]
8. Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites.
Remmel RP; Crews BC; Kozak KR; Kalgutkar AS; Marnett LJ
Drug Metab Dispos; 2004 Jan; 32(1):113-22. PubMed ID: 14709628
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations.
Egorin MJ; Rosen DM; Wolff JH; Callery PS; Musser SM; Eiseman JL
Cancer Res; 1998 Jun; 58(11):2385-96. PubMed ID: 9622079
[TBL] [Abstract][Full Text] [Related]
10. Stereochemical aspects of vinylcyclohexene bioactivation in rodent hepatic microsomes and purified human cytochrome P450 enzyme systems.
Fontaine SM; Mash EA; Hoyer PB; Sipes IG
Drug Metab Dispos; 2001 Feb; 29(2):179-84. PubMed ID: 11159809
[TBL] [Abstract][Full Text] [Related]
11. Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase.
Eldrup AB; Soleymanzadeh F; Taylor SJ; Muegge I; Farrow NA; Joseph D; McKellop K; Man CC; Kukulka A; De Lombaert S
J Med Chem; 2009 Oct; 52(19):5880-95. PubMed ID: 19746975
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation of lithocholic acid by rat hepatic microsomes: metabolite analysis by liquid chromatography/mass spectrometry.
Deo AK; Bandiera SM
Drug Metab Dispos; 2008 Feb; 36(2):442-51. PubMed ID: 18039809
[TBL] [Abstract][Full Text] [Related]
13. 3-ketocholanoic acid is the major in vitro human hepatic microsomal metabolite of lithocholic acid.
Deo AK; Bandiera SM
Drug Metab Dispos; 2009 Sep; 37(9):1938-47. PubMed ID: 19487251
[TBL] [Abstract][Full Text] [Related]
14. Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors.
Fang X; Hu S; Watanabe T; Weintraub NL; Snyder GD; Yao J; Liu Y; Shyy JY; Hammock BD; Spector AA
J Pharmacol Exp Ther; 2005 Jul; 314(1):260-70. PubMed ID: 15798002
[TBL] [Abstract][Full Text] [Related]
15. Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats.
Ghosh S; Chiang PC; Wahlstrom JL; Fujiwara H; Selbo JG; Roberds SL
Basic Clin Pharmacol Toxicol; 2008 May; 102(5):453-8. PubMed ID: 18312493
[TBL] [Abstract][Full Text] [Related]
16. Comparative metabolism of chrysene and 5-methylchrysene by rat and rainbow trout liver microsomes.
Shappell NW; Carlino-MacDonald U; Amin S; Kumar S; Sikka HC
Toxicol Sci; 2003 Apr; 72(2):260-6. PubMed ID: 12655039
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.
Kim IH; Morisseau C; Watanabe T; Hammock BD
J Med Chem; 2004 Apr; 47(8):2110-22. PubMed ID: 15056008
[TBL] [Abstract][Full Text] [Related]
18. In vitro hydroxylation and epoxidation of some isomeric lauric acid analogs by rat liver microsomes. Identification of metabolites and effects of clofibrate or phenobarbital pretreatment.
Boucher JL; Delaforge M; Salaün JP; Pinot F; Durst F; Pflieger P; Mioskowski C
Drug Metab Dispos; 1996 Apr; 24(4):462-8. PubMed ID: 8801062
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3-dodecyl urea is independent of soluble epoxide hydrolase inhibition.
Davis BB; Morisseau C; Newman JW; Pedersen TL; Hammock BD; Weiss RH
J Pharmacol Exp Ther; 2006 Feb; 316(2):815-21. PubMed ID: 16221742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
